Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on July 18, 2025

ONAR Appoints Globally Recognized Cybersecurity and AI Expert Mark Gazit to the Company’s Board of Directors
Miami, FL, July 18, 2025 (GLOBE NEWSWIRE) -- Onar Holding Corporation (OTCQB: ONAR), a leading marketing technology company and network of marketing agencies, today announced that Mark Gazit, globally recognized for his expertise in cybersecurity and AI, …

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to market EURneffy in the U.K., expects availability in late …

Rapid7 Announces Availability of InsightCloudSec and InsightAppSec in the New AWS Marketplace AI Agents and Tools category
BOSTON, July 18, 2025 (GLOBE NEWSWIRE) -- Today, Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, announced the availability of exposure management capabilities, InsightCloudSec and InsightAppSec, in the new AI Agents and …

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
GAITHERSBURG, Md., July 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the …

Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

KuCoin Launches xStocks, Delivering a One-Stop Access Point to Top Global Tokenized Equities
VICTORIA, Seychelles, July 18th, 2025, Chainwire On July 18, 2025, the leading global cryptocurrency exchange KuCoin officially announced the listing of xStocks and that they are joining the xStocks alliance. xStocks are tokenized stocks powered by the …

Generation Bio Announces 1-for-10 Reverse Stock Split
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 …

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Securing Place in Revitalized Market
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …

CEA Industries Applauds FDA Authorization of JUUL Products, Signals Opportunity for U.S. Market Expansion
Louisville, Colorado, July 18, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: VAPE) (“CEA Industries” or the “Company”), owner of Central Canada’s largest independent vape retailer and vertically integrated manufacturer, Fat Panda Ltd., today issued …

Robex remains on track for first gold at Kiniero in Q4 CY25
Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury) with 3,666,920 hours worked since January 2023. Phase 1 grade control …

Rackspace Technology to Announce Second Quarter 2025 Earnings on August 7, 2025
SAN ANTONIO, July 18, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its second quarter 2025 financial results after the market closes on …

Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics for the treatment of metabolic diseases, today announced …

AgEagle Aerial Systems eBee TAC Drone Receives Blue UAS Clearance with Department of Defense
DoD Designation Allows for Direct, Expedited U.S. Government Procurement WICHITA, Kan., July 18, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to announce …

FOXO TECHNOLOGIES INC. ANNOUNCES INTENTION TO SPIN OFF EPIGENETICS SUBSIDIARY
WEST PALM BEACH, FLORIDA, July 18, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved pursuing the spin-off of its FOXO Labs, Inc. subsidiary that is …

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease
MALVERN, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the first patient has been dosed in its Phase 2/3 GARDian3 …

Bitget Lists Yooldo Games (ESPORTS) for Spot Trading
Seychelles, Victoria, July 18th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Yooldo Games (ESPORTS) in the Innovation and GameFi Zone, adding it to spot trading. Yooldo is a multi-chain Web3 …

SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …

Successful Commercial Launch of Ryoncil®
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …